Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo

Background. Vitiligo is a chronic condition characterized by skin depigmentation. Although not life-threatening, it significantly impacts quality of life. The pathophysiology of vitiligo remains poorly understood, and treatment options are limited. Mounting evidence supports the importance of autore...

Full description

Saved in:
Bibliographic Details
Main Authors: Thai Van Thanh Le, Huy Ngoc Phan, Tran Ngoc Dang, Le Duy Pham
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/5524566
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567484674211840
author Thai Van Thanh Le
Huy Ngoc Phan
Tran Ngoc Dang
Le Duy Pham
author_facet Thai Van Thanh Le
Huy Ngoc Phan
Tran Ngoc Dang
Le Duy Pham
author_sort Thai Van Thanh Le
collection DOAJ
description Background. Vitiligo is a chronic condition characterized by skin depigmentation. Although not life-threatening, it significantly impacts quality of life. The pathophysiology of vitiligo remains poorly understood, and treatment options are limited. Mounting evidence supports the importance of autoreactive T cells and, particularly interleukin-17A- (IL-17A-) secreting Th17 cells, in vitiligo. IL-17A targeting has been proven successful in various inflammatory dermatological conditions, including psoriasis and lupus erythematosus. Objective. We evaluated the relationship between serum levels of IL-17A and the clinicopathological characteristics of Vietnamese vitiligo patients. Methods. In this cross-sectional study, we analyzed data from 52 nonsegmental vitiligo patients and 50 age- and sex-matched healthy individuals. Serum levels of IL-17A were measured using an enzyme-linked immunosorbent assay. We evaluated the correlation between IL-17A levels and clinical characteristics including leukotrichia, disease duration, vitiligo activity, and body surface area involvement. Results. Patients with progressive vitiligo had significantly higher IL-17A levels than patients with stable vitiligo (P = 0.014) or healthy individuals (P = 0.002). In addition, serum IL-17A levels were higher in vitiligo patients with leukotrichia than in patients without it (P = 0.04). Furthermore, serum IL-17A levels were negatively correlated with age (r = −0.39, P = 0.004) and age of onset (r = −0.33, P = 0.016) in vitiligo patients. Conclusions. Higher serum levels of IL-17A in patients with progressive vitiligo and leukotrichia suggest a potential role of IL-17A in melanocyte destruction in the epidermis and the follicular matrix.
format Article
id doaj-art-e690c2b6de4a460fb3781593b1cbd414
institution Kabale University
issn 1687-6105
1687-6113
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Dermatology Research and Practice
spelling doaj-art-e690c2b6de4a460fb3781593b1cbd4142025-02-03T01:01:24ZengWileyDermatology Research and Practice1687-61051687-61132021-01-01202110.1155/2021/55245665524566Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial VitiligoThai Van Thanh Le0Huy Ngoc Phan1Tran Ngoc Dang2Le Duy Pham3Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, VietnamHo Chi Minh City Hospital of Dermato-Venereology, Ho Chi Minh City, VietnamFaculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, VietnamFaculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, VietnamBackground. Vitiligo is a chronic condition characterized by skin depigmentation. Although not life-threatening, it significantly impacts quality of life. The pathophysiology of vitiligo remains poorly understood, and treatment options are limited. Mounting evidence supports the importance of autoreactive T cells and, particularly interleukin-17A- (IL-17A-) secreting Th17 cells, in vitiligo. IL-17A targeting has been proven successful in various inflammatory dermatological conditions, including psoriasis and lupus erythematosus. Objective. We evaluated the relationship between serum levels of IL-17A and the clinicopathological characteristics of Vietnamese vitiligo patients. Methods. In this cross-sectional study, we analyzed data from 52 nonsegmental vitiligo patients and 50 age- and sex-matched healthy individuals. Serum levels of IL-17A were measured using an enzyme-linked immunosorbent assay. We evaluated the correlation between IL-17A levels and clinical characteristics including leukotrichia, disease duration, vitiligo activity, and body surface area involvement. Results. Patients with progressive vitiligo had significantly higher IL-17A levels than patients with stable vitiligo (P = 0.014) or healthy individuals (P = 0.002). In addition, serum IL-17A levels were higher in vitiligo patients with leukotrichia than in patients without it (P = 0.04). Furthermore, serum IL-17A levels were negatively correlated with age (r = −0.39, P = 0.004) and age of onset (r = −0.33, P = 0.016) in vitiligo patients. Conclusions. Higher serum levels of IL-17A in patients with progressive vitiligo and leukotrichia suggest a potential role of IL-17A in melanocyte destruction in the epidermis and the follicular matrix.http://dx.doi.org/10.1155/2021/5524566
spellingShingle Thai Van Thanh Le
Huy Ngoc Phan
Tran Ngoc Dang
Le Duy Pham
Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
Dermatology Research and Practice
title Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
title_full Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
title_fullStr Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
title_full_unstemmed Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
title_short Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo
title_sort increased circulatory interleukin 17a levels in patients with progressive and leukotrichial vitiligo
url http://dx.doi.org/10.1155/2021/5524566
work_keys_str_mv AT thaivanthanhle increasedcirculatoryinterleukin17alevelsinpatientswithprogressiveandleukotrichialvitiligo
AT huyngocphan increasedcirculatoryinterleukin17alevelsinpatientswithprogressiveandleukotrichialvitiligo
AT tranngocdang increasedcirculatoryinterleukin17alevelsinpatientswithprogressiveandleukotrichialvitiligo
AT leduypham increasedcirculatoryinterleukin17alevelsinpatientswithprogressiveandleukotrichialvitiligo